Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Compassionate Use of Remdesivir in Covid-19

    Research output: Contribution to journalLetterResearchpeer-review

  3. Soluble Urokinase Receptor and Acute Kidney Injury

    Research output: Contribution to journalLetterResearchpeer-review

  4. Erythropoietin in Preterm Infants

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Association between Mental Disorders and Subsequent Medical Conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Distinct immune phenotypes in infants developing asthma during childhood

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Virulent coliphages in 1-year-old children fecal samples are fewer, but more infectious than temperate coliphages

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Fish oil supplementation during pregnancy is protective against asthma/wheeze in offspring

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background Reduced intake of n-3 long-chain polyunsaturated fatty acids (LCPUFAs) may be a contributing factor to the increasing prevalence of wheezing disorders. We assessed the effect of supplementation with n-3 LCPUFAs in pregnant women on the risk of persistent wheeze and asthma in their offspring. Methods We randomly assigned 736 pregnant women at 24 weeks of gestation to receive 2.4 g of n-3 LCPUFA (fish oil) or placebo (olive oil) per day. Their children formed the Copenhagen Prospective Studies on Asthma in Childhood2010 (COPSAC2010) cohort and were followed prospectively with extensive clinical phenotyping. Neither the investigators nor the participants were aware of group assignments during follow-up for the first 3 years of the children's lives, after which there was a 2-year follow-up period during which only the investigators were unaware of group assignments. The primary end point was persistent wheeze or asthma, and the secondary end points included lower respiratory tract infections, asthma exacerbations, eczema, and allergic sensitization. Results A total of 695 children were included in the trial, and 95.5% completed the 3-year, double-blind follow-up period. The risk of persistent wheeze or asthma in the treatment group was 16.9%, versus 23.7% in the control group (hazard ratio, 0.69; 95% confidence interval [CI], 0.49 to 0.97; P=0.035), corresponding to a relative reduction of 30.7%. Prespecified subgroup analyses suggested that the effect was strongest in the children of women whose blood levels of eicosapentaenoic acid and docosahexaenoic acid were in the lowest third of the trial population at randomization: 17.5% versus 34.1% (hazard ratio, 0.46; 95% CI, 0.25 to 0.83; P=0.011). Analyses of secondary end points showed that supplementation with n-3 LCPUFA was associated with a reduced risk of infections of the lower respiratory tract (31.7% vs. 39.1%; hazard ratio, 0.75; 95% CI, 0.58 to 0.98; P=0.033), but there was no statistically significant association between supplementation and asthma exacerbations, eczema, or allergic sensitization. Conclusions Supplementation with n-3 LCPUFA in the third trimester of pregnancy reduced the absolute risk of persistent wheeze or asthma and infections of the lower respiratory tract in offspring by approximately 7 percentage points, or one third. (Funded by the Lundbeck Foundation and others; ClinicalTrials.gov number, NCT00798226 .).

Original languageEnglish
JournalThe New England journal of medicine
Volume375
Issue number26
Pages (from-to)2530-9
Number of pages10
ISSN0028-4793
DOIs
Publication statusPublished - 29 Dec 2016

    Research areas

  • Asthma, Child, Preschool, Dietary Supplements, Double-Blind Method, Fatty Acids, Omega-3, Female, Fish Oils, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Medication Adherence, Olive Oil, Pregnancy, Pregnancy Trimester, Third, Respiratory Sounds, Respiratory Tract Infections, Risk, Journal Article, Randomized Controlled Trial

ID: 49920259